{"Symbol": "ALVOW", "AssetType": "Common Stock", "Name": "Alvotech Warrant", "Description": "Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.", "CIK": "1898416", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "", "Industry": "", "Address": "9, RUE DE BITBOURG, LUXEMBOURG, LUXEMBOURG, 1273", "OfficialSite": "https://www.alvotech.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "None", "EBITDA": "63248000", "PERatio": "None", "PEGRatio": "None", "BookValue": "-0.589", "DividendPerShare": "None", "DividendYield": "None", "EPS": "None", "RevenuePerShareTTM": "1.981", "ProfitMargin": "0.121", "OperatingMarginTTM": "-0.0262", "ReturnOnAssetsTTM": "0.0198", "ReturnOnEquityTTM": "0", "RevenueTTM": "573350000", "GrossProfitTTM": "318742000", "DilutedEPSTTM": "0", "QuarterlyEarningsGrowthYOY": "-0.584", "QuarterlyRevenueGrowthYOY": "0.106", "AnalystTargetPrice": "None", "AnalystRatingStrongBuy": "-", "AnalystRatingBuy": "-", "AnalystRatingHold": "-", "AnalystRatingSell": "-", "AnalystRatingStrongSell": "-", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "-", "PriceToBookRatio": "-", "EVToRevenue": "-", "EVToEBITDA": "-", "Beta": "0.117", "52WeekHigh": "2.98", "52WeekLow": "0.225", "50DayMovingAverage": "0", "200DayMovingAverage": "0", "SharesOutstanding": "0", "SharesFloat": "106071000", "PercentInsiders": "0.000", "PercentInstitutions": "0.000", "DividendDate": "None", "ExDividendDate": "None"}